Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 145 (5), 1367-1377.e4
- https://doi.org/10.1016/j.jaci.2019.11.038
Abstract
No abstract availableFunding Information
- MethaPharm Inc
This publication has 34 references indexed in Scilit:
- Methacholine challenge test: Diagnostic characteristics in asthmatic patients receiving controller medicationsJournal of Allergy and Clinical Immunology, 2012
- Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenEmergencias, 2012
- (Correcting) misdiagnoses of asthma: a cost effectiveness analysisBMC Pulmonary Medicine, 2011
- The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspectiveAllergy, 2010
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Confirmation of asthma in an era of overdiagnosisEuropean Respiratory Journal, 2010
- US Norms for Six Generic Health-Related Quality-of-Life Indexes From the National Health Measurement StudyMedical Care, 2007
- The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UKPrimary Care Respiratory Journal, 2007
- Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthmaJournal of Allergy and Clinical Immunology, 2004
- Development of the asthma control test: A survey for assessing asthma controlJournal of Allergy and Clinical Immunology, 2004